Incyte
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.About INCY
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas.
CEOWilliam J. Meury
CEOWilliam J. Meury
Employees2,617
Employees2,617
HeadquartersWilmington, Delaware
HeadquartersWilmington, Delaware
Founded1991
Founded1991
Employees2,617
Employees2,617
INCY Key Statistics
Market cap19.73B
Market cap19.73B
Price-Earnings ratio17.03
Price-Earnings ratio17.03
Dividend yield—
Dividend yield—
Average volume1.88M
Average volume1.88M
High today$102.47
High today$102.47
Low today$99.69
Low today$99.69
Open price$101.20
Open price$101.20
Volume2.09M
Volume2.09M
52 Week high$109.28
52 Week high$109.28
52 Week low$53.56
52 Week low$53.56
Stock Snapshot
Incyte(INCY) stock is priced at $100.05, giving the company a market capitalization of 19.73B. It carries a P/E multiple of 17.03.
As of 2025-12-04, Incyte(INCY) stock has fluctuated between $99.69 and $102.47. The current price stands at $100.05, placing the stock +0.4% above today's low and -2.4% off the high.
Incyte(INCY) shares are trading with a volume of 2.09M, against a daily average of 1.88M.
In the last year, Incyte(INCY) shares hit a 52-week high of $109.28 and a 52-week low of $53.56.
In the last year, Incyte(INCY) shares hit a 52-week high of $109.28 and a 52-week low of $53.56.
Analyst ratings
50%
of 28 ratingsBuy
39.3%
Hold
50%
Sell
10.7%
People also own
Based on the portfolios of people who own INCY. This list is generated using Robinhood data, and it’s not a recommendation.